VERICEL CORPORATION (VCEL) Debt / Equity
- 2014-09-30: Debt/Equity Ratio 0.
- 2013-03-31: Debt/Equity Ratio -0.
- 2012-12-31: Debt/Equity Ratio -0.
- 2012-09-30: Debt/Equity Ratio -0.
Complete source-backed debt/equity ratio history.
- Available history
- 2010-12-31 to 2014-09-30
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2014-09-30 | 0 |
| 2013-03-31 | -0 |
| 2012-12-31 | -0 |
| 2012-09-30 | -0 |
| 2012-06-30 | -0 |
| 2012-03-31 | -0 |
| 2011-12-31 | -0.01 |
| 2011-09-30 | -0.01 |
| 2011-06-30 | -0.01 |
| 2010-12-31 | 0.09 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2012-12-31 | -0 |
| 2011-12-31 | -0.01 |
| 2010-12-31 | 0.09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |